How do I buy Veracyte, Inc. Common Stock (VCYT) stock?

Buying Veracyte, Inc. Common Stock (VCYT) stock is now easy and instant through the Gotrade app. Download the Gotrade app from the App Store or Google Play. Create an account and verify your identity. Make a deposit. Search for the code "VCYT", then tap "Trade". Tap the "Buy" button. Enter the amount you want to buy. You have two options: Buy VCYT by number of shares. Buy fractional shares in dollars, starting from $1. Swipe up to confirm your order, and you're done!

What is the minimum investment for VCYT on Gotrade?

On Gotrade , you don't have to buy a full share. With fractional shares, you can start investing in Veracyte, Inc. Common Stock from just $1. A small budget shouldn't stop you from building a US stock portfolio.

Does Veracyte, Inc. Common Stock (VCYT) pay dividends?

At the moment, Veracyte, Inc. Common Stock (VCYT) does not pay dividends because it focuses on reinvesting profits for company growth (a growth stock). However, you can still potentially earn profit from share price increases (capital gains). Track VCYT's performance via the price chart in the Gotrade app.

Is buying VCYT on Gotrade safe and legal?

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA).

What are the market hours to buy VCYT?

You can place an order any time. It goes through when the US market (NYSE/NASDAQ) opens: 9:30 AM to 4:00 PM New York time, Monday to Friday. Pre-market and after-hours trading are open too. The market is closed on US public holidays. The Gotrade app shows whether the market is open.

How do I tell if VCYT is expensive or cheap?

There's no single perfect answer, but common approaches include: Compare valuation (e.g., P/E, P/S) against historical averages or competitors. Review revenue and earnings growth. Check margins and cash flow. Evaluate business outlook and the company's position within its industry. You can combine fundamental analysis with an investing strategy that matches your risk profile. All of the information above can be viewed directly in the Gotrade app.

Veracyte, Inc. Common Stock (VCYT) Stock Price: Nov 11 Close $25.11

Name	Title	Year Born
Mr. Marc A. Stapley	CEO & Director	1970
Ms. Rebecca Chambers	Executive VP & CFO	1978
Dr. Phillip G. Febbo M.D.	Chief Scientific & Medical Officer	1966
Ms. Annie McGuire	Executive VP, General Counsel & Head of Market Access	1980
Dr. John Leite Ph.D.	Global Chief Commercial Officer	1972
Dr. Keith Gligorich Ph.D.	Senior Vice President of Global Operations	—
Mr. Jonathan Wygant	VP & Chief Accounting Officer	1971
Dr. Kevin Richard Haas Ph.D.	Chief Development & Technology Officer	1985
Mr. Steven French	Senior VP & Chief Information Officer	—
Ms. Kelly Gura	Director of Investor Relations	—

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2021											-10.7	+8.6
2022	-28.5	-11.0	-1.7	-29.5	-18.6	+14.8	+24.8	-21.0	-16.2	+17.7	+34.3	-17.7
2023	+10.9	-5.2	-5.9	+2.1	+13.3	-2.7	+10.2	-2.4	-16.4	-5.6	+21.6	+3.7
2024	-8.7	-7.1	-7.7	-9.6	+3.1	+2.5	+12.5	+37.5	+12.4	+1.8	+25.2	-10.2
2025	+12.5	-22.9	-11.7	+3.2	-10.4	+1.1	-13.9	+28.3	+14.0	-0.4	+29.9	-9.2
2026	-10.2	-4.1	-10.6	+1.6	+40.0	+21.9	-22.6	-3.7	+6.0	+13.2	-48.8

Veracyte, Inc. Common Stock (VCYT) Stock

Key stats

Compare with VCYT

Recent news

Veracyte (VCYT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Veracyte (VCYT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?

Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares

Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?

Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?

Technical indicators

Analyst ratings

Financials

Performance

Debt & Balance Sheet

Revenue to Profit

Earnings

Latest news

Veracyte (VCYT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Veracyte (VCYT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?

Will Veracyte (VCYT) Beat Estimates Again in Its Next Earnings Report?

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares

Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares

Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?

Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?

3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes

3 Medical Instruments Stocks Banking on GenAI to Tackle Industry Woes

Is it Worth Adding Veracyte Stock to Your Portfolio Now?

Is it Worth Adding Veracyte Stock to Your Portfolio Now?

VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity?

VCYT Drops 25.3% in the Past Month. Is the Sell-Off an Opportunity?

Down 30.2% in 4 Weeks, Here's Why Veracyte (VCYT) Looks Ripe for a Turnaround

Down 30.2% in 4 Weeks, Here's Why Veracyte (VCYT) Looks Ripe for a Turnaround

Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates

Veracyte (VCYT) Q2 Earnings and Revenues Surpass Estimates

Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline

Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline

About Veracyte, Inc. Common Stock

Key Executives

Fundamentals

Valuation

Profitability

Trading

Technical indicators

Analyst views

Seasonality

Compare stocks

Market cap

Price / Earnings ratio

Price / Sales ratio

Dividend yield

Average volume

Earnings per share

Stocks in the same sector

FAQ

Trade Faster. Easier. Smarter.

#ReadyGoTrade